* This is a single-site retrospective electronic chart review of Cooper Health System Inpatients and Outpatients from 2008 through 2023 aged eighteen years or older. This review is designed as an emulation of a randomized clinical trial with a nonrandomized database. * The primary objectives are to compare healthcare costs and healthcare utilization between subjects who have corrected low vitamin D levels and those without corrected low vitamin D levels.
* The purpose of the study is to characterize healthcare costs and healthcare utilization in subjects with corrected low (\<40 ng/ml) 25-OH vitamin D levels compared to subjects with uncorrected low 25-OH vitamin D levels during a three-year period. * The primary objective of this study is to determine whether ten healthcare costs are lower and ten healthcare utilization parameters occur less frequently in patients with corrected low vitamin D levels compared to patients with uncorrected low vitamin D levels in Cooper outpatients and inpatients. The costs are: 1. total billed costs for any reason; 2. total billed costs for hospitalizations; 3. total billed costs for ICU admissions; 4. total billed costs for emergency room visits; 5. total billed costs for all other outpatient services; 6. total billed costs for urgent care visits; 7. total billed costs for primary care physician (PCP) services; 8. total billed costs for nurse practitioner (NP) services; 9. total billed costs for all other professional services; 10. total billed costs for medical pharmacy services and products. The parameters are: 1. number of hospitalizations for any reason; 2. number of ICU admissions for any reason; 3. number of emergency room visits for any reason; 4. all other outpatient services for any reason; 5. number of urgent care visits for any reason; 6. number of primary care physician visits for any reason; 7. number of nurse practitioner visits for any reason; 8. all other professional services for any reason; 9. number of medical pharmacy services for any reason; 10. number of free-standing prescriptions for any reason. * The secondary objective is to determine the effect of sufficient vitamin D levels (≥ 40 ng/ml) in subjects not requiring a prior correction on the ten healthcare costs parameters and the ten healthcare utilization parameters listed in the primary objective above.
Study Type
OBSERVATIONAL
Enrollment
9,000
Cooper Health System
Camden, New Jersey, United States
Ten healthcare costs parameters among the corrected Treatment Group and the uncorrected Control Group A.
The ten healthcare costs parameters: total billed costs for any reason; costs for hospitalizations; costs for ICU admissions; costs for emergency room visits; costs for all other outpatient services; costs for urgent care visits; costs for primary care physician (PCP) services; costs for nurse practitioner (NP) services; costs for all other professional services; and costs for medical pharmacy services and products among Treatment Group and Control Group A..
Time frame: 3 year observation period
Ten healthcare utilization parameters among the corrected Treatment Group and the uncorrected Control Group A.
The ten healthcare utilization parameters: number of hospitalizations; number of ICU admissions; number of emergency room visits; all other outpatient services; number of urgent care visits; number of primary care physician services; number of nurse practitioner services; all other professional services; number of medical pharmacy services or products; and number of free-standing prescriptions among Treatment Group and Control Group A.
Time frame: 3 year observation period
Ten healthcare costs parameters among patients with sufficient vitamin D levels (Control Group B).
The secondary outcomes are the ten healthcare costs parameters listed in the primary outcomes above relating to patients with sufficient vitamin D levels who did not require a prior correction (Control Group B).
Time frame: 3 year observation period
Ten healthcare utilization parameters among patients with sufficient vitamin D levels (Control Group B).
The secondary outcomes are the ten healthcare utilization parameters listed in the primary outcomes above relating to patients with sufficient vitamin D levels who did not require a prior correction (Control Group B).
Time frame: 3 year observation period
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.